NEW YORK R & D CENTER FOR TRANSLATIONAL MEDICINE & THERAPEUTICS INC
Advancing microRNA Therapeutics for Musculoskeletal Disease
NEW ROCHELLE, United States · Founded 2016 · $3.2M raised
- Headquarters
- NEW ROCHELLE, New York
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- nytmt.com
- Total Funding
- $3.2M
- Last Round
- $3.2M GrantApr 2025
About
New York R&D Center for Translational Medicine and Therapeutics (Ny.TmT) is an R&D company developing and commercializing therapies for musculoskeletal diseases and disorders, including osteoarthritis and tendinopathy. The company has developed a microRNA-based therapeutic designed to mitigate disease progression while providing pain relief. Headquartered in New Rochelle, NY, Ny.TmT has received multiple SBIR/STTR awards from the Department of Health and Human Services.
Summary
NEW YORK R & D CENTER FOR TRANSLATIONAL MEDICINE & THERAPEUTICS INC is a Biotech company based in NEW ROCHELLE, United States, founded in 2016. It has raised $3.2M in total, most recently a $3.2M Grant round in Apr 2025.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.